These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 5723424)
81. Pharmacological aspects of neuromuscular transmission in the thymus deficient nude (Nu/Nu) mouse. Wolfe AF; Dryden WF; Marshall IG; Pantelouris EM Exp Neurol; 1976 May; 51(2):503-9. PubMed ID: 1269576 [No Abstract] [Full Text] [Related]
82. The effects of succinylcholine and d-tubocurarine on oxygen consumption. Muldoon SM; Theye RA Anesthesiology; 1969 Nov; 31(5):437-42. PubMed ID: 5345294 [No Abstract] [Full Text] [Related]
83. Kinetics of pharmacologic activity of succinylcholine in man. Levy G J Pharm Sci; 1967 Dec; 56(12):1687-8. PubMed ID: 5588732 [No Abstract] [Full Text] [Related]
84. The pharmacology of pancuronium bromide: a new non-depolarising neuromuscular blocking agent. Buckett WR Ir J Med Sci; 1968 Dec; 7(12):565-8. PubMed ID: 5713392 [No Abstract] [Full Text] [Related]
85. Neuromuscular blockade in a patient with stiff-baby syndrome. Cook WP; Kaplan RF Anesthesiology; 1986 Nov; 65(5):525-8. PubMed ID: 3777485 [No Abstract] [Full Text] [Related]
86. Fluorimetric and chromatographic determination of pancuronium bromide and its metabolites in biological materials. Kersten UW; Meijer DK; Agoston S Clin Chim Acta; 1973 Feb; 44(1):59-66. PubMed ID: 4267643 [No Abstract] [Full Text] [Related]
87. Increased sensitivity to the muscle-relaxing effect of succinylcholine in irradiated rabbits. Belfrage P; Schildt B Acta Anaesthesiol Scand; 1967; 11(2):65-75. PubMed ID: 6029546 [No Abstract] [Full Text] [Related]
88. Self-taming of succinylcholine-induced fasciculations. Baraka A Anesthesiology; 1977 Apr; 46(4):292-3. PubMed ID: 842886 [No Abstract] [Full Text] [Related]
89. Receptor subunit compositions underly distinct potencies of a muscle relaxant in fast and slow muscle fibers. Yamashita M; Egashira Y; Nakamura S; Sakata S; Ono F Front Physiol; 2022; 13():1026646. PubMed ID: 36304584 [TBL] [Abstract][Full Text] [Related]
90. Why all muscles are not alike. Storella RJ Can J Anaesth; 1996 Jun; 43(6):549-33. PubMed ID: 8773858 [No Abstract] [Full Text] [Related]
91. New techniques of measurement of relaxants and their antagonists. Kaufman L Proc R Soc Med; 1970 Jul; 63(7):696-7. PubMed ID: 5434222 [No Abstract] [Full Text] [Related]
92. The effect of pancuronium on reflex regulation of heart rate in man. Duke PC; Mittler G; Wade JG Can Anaesth Soc J; 1974 Mar; 21(2):139-46. PubMed ID: 4362101 [No Abstract] [Full Text] [Related]
93. Pancuronium bromide: a review of its pharmacological properties and clinical application. Speight TM; Avery GS Drugs; 1972; 4(3):163-226. PubMed ID: 4264763 [No Abstract] [Full Text] [Related]
95. Some effects of the steroidal muscle relaxant, dacuronium bromide, in anaesthetized patients. Norman J; Katz RL Br J Anaesth; 1971 Apr; 43(4):313-9. PubMed ID: 4252525 [No Abstract] [Full Text] [Related]
96. The neuromuscular blocking properties of a new steroid compound, pancuronium bromide. A pilot study in man. Baird WL; Reid AM Br J Anaesth; 1967 Oct; 39(10):775-80. PubMed ID: 6073464 [No Abstract] [Full Text] [Related]
97. Different potency of pancuronium bromide on two types of skeletal muscle. Bonta IL; Goorissen EM Eur J Pharmacol; 1968 Oct; 4(3):303-8. PubMed ID: 5723424 [No Abstract] [Full Text] [Related]
98. Initial experience during the clinical use of pancuronium bromide. McIntyre JW; Gain EA Anesth Analg; 1971; 50(5):813-23. PubMed ID: 4255896 [No Abstract] [Full Text] [Related]